Zainah Adam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zainah Adam has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Muhajir Hamid
Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
3 shared publications - Nur Sumirah Mohd Dom
Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Seri Kembangan, Selangor, Malaysia
2 shared publications - Nurshieren Yahaya
Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Seri Kembangan, Selangor, Malaysia
2 shared publications Aishah Adam
Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia
1 shared publicationDaryl J. Arapoc
Malaysian Nuclear Agency, 43000 Kajang, Selangor, Malaysia
1 shared publication- Hasnah Bahari
Department of Human Anatomy, Faculty of Medicine and Health Sciences Universiti Putra Malaysia Serdang Selangor Malaysia
1 shared publication
Latest Publications
- Open Access
- 10 December 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-17
Surface functionalisation of poly-APO-b-polyol ester cross-linked copolymers as core–shell nanoparticles for targeted breast cancer therapy
Polymeric nanoparticles (NPs) are commonly used as nanocarriers for drug delivery, whereby their sizes can be altered for a more efficient delivery of therapeutic active agents with better efficacy. In this work, cross-linked copolymers acted as core–shell NPs from acrylated palm olein (APO) with polyol ester were synthesized via gamma radiation-induced reversible addition-fragmentation chain transfer (RAFT) polymerisation. The particle diameter of the copolymerised poly(APO-b-polyol ester) core–shell NPs was found to be less than 300 nm, have a low molecular weight (MW) of around 24 kDa, and showed a controlled MW distribution of a narrow polydispersity index (PDI) of 1.01. These properties were particularly crucial for further use in designing targeted NPs, with inclusion of peptide for the targeted delivery of paclitaxel. Moreover, the characterisation of the synthesised NPs using Fourier Transform-Infrared (FTIR) and Neutron Magnetic Resonance (NMR) analyses confirmed the possession of biodegradable hydrolysed ester in its chemical structures. Therefore, it can be concluded that the synthesised NPs produced may potentially contribute to better development of a nano-structured drug delivery system for breast cancer therapy.
- 10 December 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-17
Open AccessSurface functionalisation of poly-APO-b-polyol ester cross-linked copolymers as core–shell nanoparticles for targeted breast cancer therapy
Polymeric nanoparticles (NPs) are commonly used as nanocarriers for drug delivery, whereby their sizes can be altered for a more efficient delivery of therapeutic active agents with better efficacy. In this work, cross-linked copolymers acted as core–shell NPs from acrylated palm olein (APO) with polyol ester were synthesized via gamma radiation-induced reversible addition-fragmentation chain transfer (RAFT) polymerisation. The particle diameter of the copolymerised poly(APO-b-polyol ester) core–shell NPs was found to be less than 300 nm, have a low molecular weight (MW) of around 24 kDa, and showed a controlled MW distribution of a narrow polydispersity index (PDI) of 1.01. These properties were particularly crucial for further use in designing targeted NPs, with inclusion of peptide for the targeted delivery of paclitaxel. Moreover, the characterisation of the synthesised NPs using Fourier Transform-Infrared (FTIR) and Neutron Magnetic Resonance (NMR) analyses confirmed the possession of biodegradable hydrolysed ester in its chemical structures. Therefore, it can be concluded that the synthesised NPs produced may potentially contribute to better development of a nano-structured drug delivery system for breast cancer therapy.
- Open Access
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 6374632
Antiglycation and Antioxidant Properties of Ficus deltoidea Varieties
The present study aimed to evaluate the potential of standardized methanolic extracts from seven Ficus deltoidea varieties in inhibiting the formation of AGEs, protein oxidation, and their antioxidant effects. The antiglycation activity was analyzed based on the inhibition of AGEs, fructosamine, and thiol groups level followed by the inhibition of protein carbonyl formation. The antioxidant activity (DPPH radical scavenging activity and reducing power assay) and total phenolic contents were evaluated. After 28 days of induction, all varieties of Ficus deltoidea extracts significantly restrained the formation of fluorescence AGEs by 4.55–5.14 fold. The extracts also reduced the fructosamine levels by 47.0–86.5%, increased the thiol group levels by 64.3–83.7%, and inhibited the formation of protein carbonyl by 1.36–1.76 fold. DPPH radical scavenging activity showed an IC50 value of 66.81–288.04 μg/ml and reducing power activity depicted at 0.02–0.24 μg/ml. The extent of phenolic compounds present in the extracts ranged from 70.90 to 299.78 mg·GAE/g. Apart from that, correlation studies between the activities were observed. This study revealed that seven varieties of Ficus deltoidea have the potential to inhibit AGEs formation and possess antioxidant activity that might be attributed to the presence of phenolic compounds.
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 6374632
Open AccessAntiglycation and Antioxidant Properties of Ficus deltoidea Varieties
The present study aimed to evaluate the potential of standardized methanolic extracts from seven Ficus deltoidea varieties in inhibiting the formation of AGEs, protein oxidation, and their antioxidant effects. The antiglycation activity was analyzed based on the inhibition of AGEs, fructosamine, and thiol groups level followed by the inhibition of protein carbonyl formation. The antioxidant activity (DPPH radical scavenging activity and reducing power assay) and total phenolic contents were evaluated. After 28 days of induction, all varieties of Ficus deltoidea extracts significantly restrained the formation of fluorescence AGEs by 4.55–5.14 fold. The extracts also reduced the fructosamine levels by 47.0–86.5%, increased the thiol group levels by 64.3–83.7%, and inhibited the formation of protein carbonyl by 1.36–1.76 fold. DPPH radical scavenging activity showed an IC50 value of 66.81–288.04 μg/ml and reducing power activity depicted at 0.02–0.24 μg/ml. The extent of phenolic compounds present in the extracts ranged from 70.90 to 299.78 mg·GAE/g. Apart from that, correlation studies between the activities were observed. This study revealed that seven varieties of Ficus deltoidea have the potential to inhibit AGEs formation and possess antioxidant activity that might be attributed to the presence of phenolic compounds.
- Open Access
- 6 March 2019
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2019, 1-9
Momordica charantia (Indian and Chinese Bitter Melon) Extracts Inducing Apoptosis in Human Lung Cancer Cell Line A549 via ROS-Mediated Mitochodria Injury
Lung cancer is the leading cause of cancer related deaths worldwide with about 40% occurring in developing countries. The two varieties of Momordica charantia, which are Chinese and Indian bitter melon, have been subjected to antiproliferative activity in human non-small cell lung cells A549. The A549 cells were treated with hot and cold aqueous extraction for both the bitter melon varieties, and the antiproliferative activity was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The apoptotic mechanism of action on A549 human lung cancer cells was evaluated first morphologically using Hoechst 33358, and cytoskeleton staining using Filamentous-actin (F-actin) cytoskeleton FICT and DAPI followed by caspase-3/7, reactive oxygen species (ROS), and p53 activity. Chinese hot aqueous extraction (CHA) exhibited potent antiproliferative activity against A549 human lung cancer cells. The morphological analysis of mitochondria destruction and the derangement of cytoskeleton showed apoptosis-inducing activity. CHA increased the caspase-3/7 activity by 1.6-fold and the ROS activity by 5-fold. Flow cytometric analysis revealed 34.5% of apoptotic cells significantly (p<0.05) compared to cisplatin-treated A549 human cancer cells. CHA is suggested to induce apoptosis due to their rich bioactive chemical constituents. These findings suggest that the antiproliferative effect of CHA was due to apoptosis via ROS-mediated mitochondria injury.
- 6 March 2019
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2019, 1-9
Open AccessMomordica charantia (Indian and Chinese Bitter Melon) Extracts Inducing Apoptosis in Human Lung Cancer Cell Line A549 via ROS-Mediated Mitochodria Injury
Lung cancer is the leading cause of cancer related deaths worldwide with about 40% occurring in developing countries. The two varieties of Momordica charantia, which are Chinese and Indian bitter melon, have been subjected to antiproliferative activity in human non-small cell lung cells A549. The A549 cells were treated with hot and cold aqueous extraction for both the bitter melon varieties, and the antiproliferative activity was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The apoptotic mechanism of action on A549 human lung cancer cells was evaluated first morphologically using Hoechst 33358, and cytoskeleton staining using Filamentous-actin (F-actin) cytoskeleton FICT and DAPI followed by caspase-3/7, reactive oxygen species (ROS), and p53 activity. Chinese hot aqueous extraction (CHA) exhibited potent antiproliferative activity against A549 human lung cancer cells. The morphological analysis of mitochondria destruction and the derangement of cytoskeleton showed apoptosis-inducing activity. CHA increased the caspase-3/7 activity by 1.6-fold and the ROS activity by 5-fold. Flow cytometric analysis revealed 34.5% of apoptotic cells significantly (p<0.05) compared to cisplatin-treated A549 human cancer cells. CHA is suggested to induce apoptosis due to their rich bioactive chemical constituents. These findings suggest that the antiproliferative effect of CHA was due to apoptosis via ROS-mediated mitochondria injury.
- Open Access
- 1 January 2018
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 3769874
Insulinotropic Activity of Standardized Methanolic Extracts of Ficus deltoidea from Seven Varieties
Ficus deltoidea is a traditional medicinal plant that has been proven to show antidiabetic effects. This study focus is to assess the insulin secretion activity of Ficus deltoidea standardized methanolic extracts from seven independent varieties and mechanisms that underlie the insulin secretion action of the extracts. The cytotoxicity of Ficus deltoidea extracts was tested using viability assay. The insulin secretion assay was carried out by treating clonal BRIN BD11 cell line with standardized methanolic Ficus deltoidea extracts or glybenclamide. The clonal BRIN BD11 cell was also treated with insulin agonist and antagonist to elucidate the insulin secretion mechanism. Only the viability percentage for Ficus deltoidea var. kunstleri and intermedia was identified to be toxic at 500 and 1000 μg/ml (PFicus deltoidea var. deltoidea, angustifolia, and motleyana was dose‐dependent; further evaluation suggested that Ficus deltoidea var. trengganuensis was involved in KATP‐independent pathway. This study suggests that standardized methanolic extracts of Ficus deltoidea varieties have an insulinotropic effect on clonal BRIN BD11 cell line and can be utilized as a modern candidate of antidiabetic agents targeting the escalation for insulin secretion from pancreatic beta cells.
- 1 January 2018
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 3769874
Open AccessInsulinotropic Activity of Standardized Methanolic Extracts of Ficus deltoidea from Seven Varieties
Ficus deltoidea is a traditional medicinal plant that has been proven to show antidiabetic effects. This study focus is to assess the insulin secretion activity of Ficus deltoidea standardized methanolic extracts from seven independent varieties and mechanisms that underlie the insulin secretion action of the extracts. The cytotoxicity of Ficus deltoidea extracts was tested using viability assay. The insulin secretion assay was carried out by treating clonal BRIN BD11 cell line with standardized methanolic Ficus deltoidea extracts or glybenclamide. The clonal BRIN BD11 cell was also treated with insulin agonist and antagonist to elucidate the insulin secretion mechanism. Only the viability percentage for Ficus deltoidea var. kunstleri and intermedia was identified to be toxic at 500 and 1000 μg/ml (PFicus deltoidea var. deltoidea, angustifolia, and motleyana was dose‐dependent; further evaluation suggested that Ficus deltoidea var. trengganuensis was involved in KATP‐independent pathway. This study suggests that standardized methanolic extracts of Ficus deltoidea varieties have an insulinotropic effect on clonal BRIN BD11 cell line and can be utilized as a modern candidate of antidiabetic agents targeting the escalation for insulin secretion from pancreatic beta cells.
- 24 October 2017
- Published by Georg Thieme Verlag KG
- Vol. 4 (S 01) , Tu-PO-93
Inhibition of advanced glycation end-products formation and antioxidant properties of Ficus deltoidea var. intermedia
Increased protein glycation and build-up of tissue advanced glycation end-products (AGEs) have been implicated in diabetic complications. By inhibiting the formation of AGEs would certainly prevent the occurrence of diabetic complications. Compounds with combined antiglycation and antioxidant properties may offer thereapeutic potential and possibly help on minimizing the complications of diabetes. The present study was performed to evaluate the in vitro antiglycation activity of Ficus deltoidea var. intermedia using fructose as a reducing sugar. The antiglycation activity was analyzed based on the inhibition of AGEs formation (24 hours, 14 and 28 days), the level of fructosamine, level of thiol group and inhibition of protein carbonyl. The antioxidant activity was measured using total phenolic content, DPPH radical scavenging activity and ferric reducing power assay. The plant extract was incubated with BSA and fructose for 24 hours at 60 °C and the IC50value of theinhibition of AGEs formation was found at 1.708 ± 0.06 mg/ml. During 4 weeks of study, Ficus deltoidea var. intermedia extract (78.1 – 5000 µg/ml) significantly inhibited the formation of fluorescence AGEs. The plant extract also decreased the level of fructosamine, the thiol group and inhibited the formation of protein carbonyl. This promising antiglycation activity may be attributed by the amount of phenolic compounds presence in the extract showed 188.58 ± 9.36 mg GAE/g of extract. Meanwhile, for DPPH assay, the extract showed IC50 value at 78.96 ± 6.25 mg/ml and ferric reducing power measured at 700nm depicted 0.453 ± 0.04 (p < 0.05) compared to ascorbic acid. This study suggested that Ficus deltoidea var. intermedia have the ability to inhibit the formation of AGEs, decrease oxidative stress and may have the potential to be developed as new therapeutic agents to prevent the pathogenesis of diabetic complications.
- 24 October 2017
- Published by Georg Thieme Verlag KG
- Vol. 4 (S 01) , Tu-PO-93
Inhibition of advanced glycation end-products formation and antioxidant properties of Ficus deltoidea var. intermedia
Increased protein glycation and build-up of tissue advanced glycation end-products (AGEs) have been implicated in diabetic complications. By inhibiting the formation of AGEs would certainly prevent the occurrence of diabetic complications. Compounds with combined antiglycation and antioxidant properties may offer thereapeutic potential and possibly help on minimizing the complications of diabetes. The present study was performed to evaluate the in vitro antiglycation activity of Ficus deltoidea var. intermedia using fructose as a reducing sugar. The antiglycation activity was analyzed based on the inhibition of AGEs formation (24 hours, 14 and 28 days), the level of fructosamine, level of thiol group and inhibition of protein carbonyl. The antioxidant activity was measured using total phenolic content, DPPH radical scavenging activity and ferric reducing power assay. The plant extract was incubated with BSA and fructose for 24 hours at 60 °C and the IC50value of theinhibition of AGEs formation was found at 1.708 ± 0.06 mg/ml. During 4 weeks of study, Ficus deltoidea var. intermedia extract (78.1 – 5000 µg/ml) significantly inhibited the formation of fluorescence AGEs. The plant extract also decreased the level of fructosamine, the thiol group and inhibited the formation of protein carbonyl. This promising antiglycation activity may be attributed by the amount of phenolic compounds presence in the extract showed 188.58 ± 9.36 mg GAE/g of extract. Meanwhile, for DPPH assay, the extract showed IC50 value at 78.96 ± 6.25 mg/ml and ferric reducing power measured at 700nm depicted 0.453 ± 0.04 (p < 0.05) compared to ascorbic acid. This study suggested that Ficus deltoidea var. intermedia have the ability to inhibit the formation of AGEs, decrease oxidative stress and may have the potential to be developed as new therapeutic agents to prevent the pathogenesis of diabetic complications.
- Open Access
- 1 January 2016
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2016 (1) , 2467420
Corrigendum to “Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3‐L1 Adipocytes”
[This corrects the article DOI: 10.1155/2013/938081.].
- 1 January 2016
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2016 (1) , 2467420
Open AccessCorrigendum to “Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3‐L1 Adipocytes”
[This corrects the article DOI: 10.1155/2013/938081.].